Ireland· IE-PA-EU/1/24/1815/001-014
Awiqli 700 units/mL solution for injection in pre-filled pen
A insulin icodec product containing insulin icodec, registered in Ireland by Novo Nordisk A/S. The same ATC class is registered in 9 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Insulin icodec is registered in 9 of 19 countries.
Countries holding a registration under ATC A10AE07 (insulin icodec), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
Insulin icodec · ATC A10AE07
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Insulin icodec
- Manufacturer
- Novo Nordisk A/S
- Country
- Ireland (IE)
- ATC code
- A10AE07
- ATC class
- Insulin icodec
- Defined daily dose
- 40 E, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/24/1815/001-014
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Insulin icodec in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAWIQLINovo Nordisk A/S, Bagsvaerd
- BelgiumAwiqli 700 U/mlNovo Nordisk
- SwitzerlandAwiqli FlexTouch 700 E/ml, Injektionslösung im FertigpenNovo Nordisk Pharma AG
- United StatesAwiqliNovo Nordisk
- CanadaAWIQLINOVO NORDISK CANADA INC
- Japanインスリン イコデク（遺伝子組換え）ノボ ノルディスク ファーマ
- ItalyAWIQLI*1 penna preriempita SC 700 U/ml 1,5 ml + 14 aghiNOVO NORDISK A/S
- FinlandAwiqliNovo Nordisk A/S
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Awiqli
- Norway · Awiqli
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f699c2d5-e9c3-4351-8ba3-de31fe9abdad GET /v1/drugs/f699c2d5-e9c3-4351-8ba3-de31fe9abdad?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled pen",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"A10AE07"
],
"strength": null,
"pa_number": "EU/1/24/1815/001-014",
"substances": [
"Insulin icodec"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "17/05/2024",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about insulin icodec.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.